ArticleBritish journal of cancer2017

Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma.

Woo Jin Bae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.